Skip to main content

Financial News

  • NY Post: Cerberus Capital emerges as potential white knight in Walgreens deal

  • Prestige Brands completes C.B. Fleet acquisition

    TARRYTOWN, N.Y. — Prestige Brands completed its previously announced acquisition of C.B. Fleet for $825 million.

     As part of the transaction, Prestige Brands acquired multiple feminine hygiene, gastrointestinal care and infant care over-the-counter brands, including Summer's Eve, Fleet, and Pedia-Lax, as well as a "mix and fill" manufacturing facility in Lynchburg Va. 

    The merger was first announced on Dec. 22. Prestige Brands announced the transaction was completed via a Form 8-K filed with the U.S. Securities and Exchange Commission.

  • Retail execs optimistic about 2017 in survey

    Retailers executives are bullish on 2017.
     
    That’s according to a survey from TD Bank, which polled 173 retail executives at the National Retail Federation’s annual Big Show in New York City. Seventy-four percent of the retailers said they believe sales will increase in the next 12 months. What’s more, 81% of the retailers reported that they met or exceeded their revenue goals in 2016.
     
    In other key findings:

  • J&J exploring strategic options for LifeScan unit

    NEW BRUNSWICK, N.J.  — Johnson and Johnson on Tuesday announced it will be evaluating "potential strategic options" for its LifeScan diabetes business, as well as other J&J diabetes banners including Animas Corp. and Calibra Medical.

    The news was announced in conjunction with the company's fourth quarter earnings call, and is part of the company's ongoing portfolio management.

  • Federal judge blocks Aetna, Humana merger, citing competition concerns

    WASHINGTON — The proposed $37 billion merger between Aetna and Humana hit a roadblock Monday, when U.S. District Court Judge John Bates issued his ruling in a lawsuit between the companies and the federal government. The Dept. of Justice sued on behalf of 264 counties in 21 states where it said a merger would limit competition unlawfully in the Medicare Advantage markets and 17 counties in three states where it said public exchange competition would be limited.
     

  • Analyst: Walgreens' Rite Aid deal still on point

    NEW YORK — Challenging "vague" reports suggesting the Walgreens deal to acquire Rite Aid may be in jeopardy, Deutsche Bank on Friday issued a research note outlining the number of options Walgreens still has at its disposal leading up to the Jan. 27 deadline.

  • Teva completes sale of U.K., Ireland Actavis business to Intas’s Accord Healthcare

    JERUSALEM and AHMEDABAD, India — The sale of Teva’s Actavis U.K. and Actavis Ireland to Intas Pharmaceuticals through its subsidiary Accord Healthcare for £603 million, Intas announced Tuesday. The transaction is part of the European Commission’s antitrust divestiture requirements surrounding Teva’s acquisition of Allergan’s generics business. 
     

  • Takeda to acquire Ariad Pharmaceuticals

    CAMBRIDGE, Mass. And OSAKA, Japan — Takeda on Monday announced its plan to acquire Ariad Pharmaceuticals for approximately $5.2 billion. The boards of both companies unanimously approved the transaction, and the companies expect it to close by the end of February. 
     
X
This ad will auto-close in 10 seconds